This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Encodia, Inc.. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Kevin Desai: Innovator in Modified Cleavases
Introduction
Kevin Desai is a notable inventor based in San Diego, California. He has made significant contributions to the field of biochemistry through his innovative work on modified cleavases. With a total of two patents to his name, Desai is recognized for his advancements in the treatment of polypeptides and proteins.
Latest Patents
Desai's latest patents focus on modified cleavases that are designed to remove amino acids from peptides, polypeptides, and proteins. These patents provide methods for utilizing the modified cleavases in treating polypeptides, as well as kits that include these cleavases. In some instances, the methods and kits also incorporate additional components for macromolecule sequencing and analysis.
Career Highlights
Kevin Desai is currently employed at Encodia, Inc., where he continues to develop innovative solutions in the field of biochemistry. His work has garnered attention for its potential applications in various scientific and medical fields.
Collaborations
Desai collaborates with esteemed colleagues, including Kevin L Gunderson and Robert C James, who contribute to his research and development efforts.
Conclusion
Kevin Desai's contributions to the field of biochemistry through his patents on modified cleavases highlight his role as an influential inventor. His work not only advances scientific understanding but also paves the way for future innovations in protein treatment and analysis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile